Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Edgewise Therapeutics has the lowest figure of the 115 health care companies ranked by P/E ratio, at 4.9, followed by Alnylam Pharmaceuticals (7.5) and Universal Health Services (7.8). Figures as of 19 Nov 2026, 08:06 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- Lowest
- Edgewise Therapeutics4.9
- Median
- 30.7
- Combined market value
- NOK 88.43T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Edgewise TherapeuticsEWTX · Health Care | 4.9 | NOK 44B | NOK 402.22 | 1.59% down | 88% up | ||
| 2 | Alnylam PharmaceuticalsALNY · Health Care | 7.5 | NOK 194.5B | NOK 1,452.53 | 4.54% down | 66% down | ||
| 3 | Universal Health ServicesUHS · Health Care | 7.8 | NOK 104.3B | NOK 1,809.05 | 3.08% down | 16% down | ||
| 4 | Tenet HealthcareTHC · Health Care | 7.9 | NOK 210B | NOK 2,638.07 | 3.80% down | 45% up | ||
| 5 | CVS HealthCVS · Health Care | 9.4 | NOK 1.01T | NOK 790.92 | 5.20% down | 12% up | ||
| 6 | Bio-Rad LaboratoriesBIO · Health Care | 9.8 | NOK 96.8B | NOK 3,598.94 | 3.34% up | 18% up | ||
| 7 | Novo NordiskNVO · Health Care | 10.0 | NOK 1.69T | NOK 383.35 | 3.12% down | 17% down | ||
| 8 | GrifolsGRFS · Health Care | 10.2 | NOK 56B | NOK 82.35 | 1.85% down | 1% up | ||
| 9 | Caris Life SciencesCAI · Health Care | 11.7 | NOK 54.4B | NOK 189.59 | 2.21% down | 17% down | ||
| 10 | Fresenius Medical CareFMS · Health Care | 12.1 | NOK 105.7B | NOK 203.68 | 3.41% down | 5% down | ||
| 11 | DaVitaDVA · Health Care | 12.2 | NOK 98.9B | NOK 1,572.99 | 6.48% down | 50% up | ||
| 12 | Oscar HealthOSCR · Health Care | 12.3 | NOK 83.3B | NOK 268.05 | 7.61% down | 112% up | ||
| 13 | Cigna GroupCI · Health Care | 12.6 | NOK 731.1B | NOK 2,774.48 | 2.96% down | 8% up | ||
| 14 | Bristol-Myers SquibbBMY · Health Care | 13.2 | NOK 1.18T | NOK 579.07 | 2.92% down | 34% up | ||
| 15 | ZoetisZTS · Health Care | 14.6 | NOK 338B | NOK 831.94 | 2.50% up | 29% down | ||
| 16 | HCA HealthcareHCA · Health Care | 15.8 | NOK 967.4B | NOK 4,631.26 | 4.96% down | 4% up | ||
| 17 | GSKGSK · Health Care | 16.9 | NOK 946.7B | NOK 472.31 | 1.34% down | 6% up | ||
| 18 | Elevance HealthELV · Health Care | 17.0 | NOK 842B | NOK 3,897.12 | 7.63% down | 37% up | ||
| 19 | Globus MedicalGMED · Health Care | 17.4 | NOK 90.8B | NOK 685.72 | 0.77% up | 16% down | ||
| 20 | GE HealthCare TechnologiesGEHC · Health Care | 17.7 | NOK 367.8B | NOK 813.38 | 2.22% up | 13% up | ||
| 21 | Ascendis PharmaASND · Health Care | 17.8 | NOK 172.4B | NOK 2,628.25 | 0.32% down | 28% up | ||
| 22 | Boston ScientificBSX · Health Care | 18.4 | NOK 615B | NOK 424.29 | 1.42% up | 56% down | ||
| 23 | CencoraCOR · Health Care | 19.4 | NOK 646.2B | NOK 3,386.41 | 0.64% down | 3% down | ||
| 24 | UnitedHealth GroupUNH · Health Care | 20.0 | NOK 3.05T | NOK 3,401.96 | 10.21% down | 26% up | ||
| 25 | ExelixisEXEL · Health Care | 20.4 | NOK 162B | NOK 663.94 | 0.31% down | 63% up | ||
| 26 | Smith & NephewSNN · Health Care | 20.6 | NOK 123.3B | NOK 294.78 | 0.62% down | 5% down | ||
| 27 | Cooper CompaniesCOO · Health Care | 20.9 | NOK 112.3B | NOK 590.64 | 0.05% up | 16% down | ||
| 28 | Regeneron PharmaceuticalsREGN · Health Care | 20.9 | NOK 951B | NOK 9,192.81 | 1.28% down | 36% up | ||
| 29 | Encompass HealthEHC · Health Care | 21.6 | NOK 128.7B | NOK 1,311.84 | 2.14% down | 23% up | ||
| 30 | United TherapeuticsUTHR · Health Care | 21.8 | NOK 239.1B | NOK 5,613.12 | 1.16% down | 23% up | ||
| 31 | ResMedRMD · Health Care | 22.1 | NOK 331.8B | NOK 2,358.75 | 2.00% up | 3% down | ||
| 32 | MSA SafetyMSA · Health Care | 22.8 | NOK 66.5B | NOK 1,725.24 | 2.67% up | 11% up | ||
| 33 | InsuletPODD · Health Care | 22.9 | NOK 94.4B | NOK 1,360.94 | 3.69% down | 58% down | ||
| 34 | Option Care HealthOPCH · Health Care | 23.0 | NOK 46.2B | NOK 308.30 | 0.25% up | 14% up | ||
| 35 | CenteneCNC · Health Care | 23.2 | NOK 324.7B | NOK 655.78 | 7.03% down | 102% up | ||
| 36 | SanofiSNY · Health Care | 23.4 | NOK 1.1T | NOK 458.12 | 0.86% down | 4% down | ||
| 37 | Henry ScheinHSIC · Health Care | 23.5 | NOK 92.1B | NOK 833.11 | 3.32% up | 17% up | ||
| 38 | Align TechnologyALGN · Health Care | 23.9 | NOK 112.4B | NOK 1,594.08 | 0.31% up | 22% up | ||
| 39 | Halozyme TherapeuticsHALO · Health Care | 23.9 | NOK 106.2B | NOK 931.40 | 0.18% down | 37% up | ||
| 40 | Neurocrine BiosciencesNBIX · Health Care | 24.2 | NOK 160.3B | NOK 1,583.39 | 1.84% down | 20% up | ||
| 41 | MedtronicMDT · Health Care | 24.7 | NOK 1.25T | NOK 979.24 | 1.56% down | 2% up | ||
| 42 | Concentra Group Holdings ParentCON · Health Care | 24.8 | NOK 51.3B | NOK 408.15 | 0.94% down | 120% up | ||
| 43 | AstraZenecaAZN · Health Care | 25.3 | NOK 2.7T | NOK 1,737.97 | 1.93% down | 2% up | ||
| 44 | Lantheus HoldingsLNTH · Health Care | 25.4 | NOK 64.9B | NOK 991.68 | 0.20% up | 93% up | ||
| 45 | AmgenAMGN · Health Care | 25.7 | NOK 2.33T | NOK 4,315.67 | 3.07% down | 34% up | ||
| 46 | Quest DiagnosticsDGX · Health Care | 25.9 | NOK 277.8B | NOK 2,524.81 | 1.30% up | 38% up | ||
| 47 | Koninklijke PhilipsPHG · Health Care | 25.9 | NOK 283.3B | NOK 289.82 | 0.27% down | 10% up | ||
| 48 | Zimmer Biomet HoldingsZBH · Health Care | 26.1 | NOK 190.1B | NOK 1,004.52 | 1.20% up | 14% up | ||
| 49 | ChemedCHE · Health Care | 26.2 | NOK 68.9B | NOK 5,315.42 | 0.01% down | 27% up | ||
| 50 | PACS GroupPACS · Health Care | 26.3 | NOK 71.4B | NOK 450.15 | 4.63% down | 188% up | ||
| 51 | QiagenQGEN · Health Care | 26.8 | NOK 99.5B | NOK 481.84 | 0.38% down | 12% up | ||
| 52 | Protagonist TherapeuticsPTGX · Health Care | 26.9 | NOK 80.7B | NOK 1,236.30 | 2.00% up | 46% up | ||
| 53 | LivaNovaLIVN · Health Care | 27.1 | NOK 50.6B | NOK 919.15 | 2.85% up | 71% up | ||
| 54 | Ensign GroupENSG · Health Care | 27.2 | NOK 103.8B | NOK 1,779.00 | 1.63% down | 4% up | ||
| 55 | McKessonMCK · Health Care | 28.0 | NOK 1.22T | NOK 10,543.25 | 0.66% down | 28% up | ||
| 56 | NovartisNVS · Health Care | 29.6 | NOK 2.85T | NOK 1,509.01 | 2.46% down | 25% up | ||
| 57 | Labcorp HoldingsLH · Health Care | 30.4 | NOK 292.7B | NOK 3,604.87 | 0.69% up | 41% up | ||
| 58 | AvantorAVTR · Health Care | 30.7 | NOK 101.3B | NOK 149.43 | 1.25% up | 38% up | ||
| 59 | STERISSTE · Health Care | 30.8 | NOK 245.1B | NOK 2,523.64 | 0.84% up | 1% up | ||
| 60 | IQVIA HoldingsIQV · Health Care | 31.4 | NOK 413.1B | NOK 2,506.82 | 0.09% up | 18% up | ||
| 61 | Merit Medical SystemsMMSI · Health Care | 32.2 | NOK 50.1B | NOK 835.44 | 1.70% up | 1% up | ||
| 62 | DexComDXCM · Health Care | 32.5 | NOK 299.2B | NOK 802.29 | 0.59% up | 37% up | ||
| 63 | argenxARGX · Health Care | 32.6 | NOK 575.5B | NOK 9,151.20 | 0.66% down | 4% up | ||
| 64 | StrykerSYK · Health Care | 33.9 | NOK 1.18T | NOK 3,093.18 | 0.19% up | 13% down | ||
| 65 | Vertex PharmaceuticalsVRTX · Health Care | 34.5 | NOK 1.32T | NOK 5,215.58 | 0.42% up | 27% up | ||
| 66 | Agilent TechnologiesA · Health Care | 35.0 | NOK 486.1B | NOK 1,724.07 | 2.97% up | 19% up | ||
| 67 | HealthEquityHQY · Health Care | 35.1 | NOK 78.3B | NOK 946.09 | 4.45% down | 2% down | ||
| 68 | Medpace HoldingsMEDP · Health Care | 35.9 | NOK 175.9B | NOK 6,289.12 | 0.95% down | 10% up | ||
| 69 | Cardinal HealthCAH · Health Care | 36.0 | NOK 625.4B | NOK 2,705.94 | 0.33% down | 35% up | ||
| 70 | IlluminaILMN · Health Care | 36.1 | NOK 308.7B | NOK 2,041.80 | 3.65% up | 69% up | ||
| 71 | Thermo Fisher ScientificTMO · Health Care | 36.5 | NOK 2.5T | NOK 6,735.09 | 0.87% up | 20% up | ||
| 72 | HumanaHUM · Health Care | 37.6 | NOK 450.5B | NOK 3,750.70 | 12.98% down | 94% up | ||
| 73 | Mettler-Toledo InternationalMTD · Health Care | 37.7 | NOK 336B | NOK 16,890.32 | 1.42% up | 22% up | ||
| 74 | DanaherDHR · Health Care | 37.8 | NOK 1.56T | NOK 2,222.34 | 1.24% up | 2% up | ||
| 75 | Abbott LaboratoriesABT · Health Care | 39.0 | NOK 1.76T | NOK 1,015.80 | 0.22% down | 17% down | ||
| 76 | PfizerPFE · Health Care | 40.1 | NOK 1.55T | NOK 272.81 | 1.44% down | 14% up | ||
| 77 | Johnson & JohnsonJNJ · Health Care | 41.4 | NOK 6.38T | NOK 2,651.30 | 2.15% down | 38% up | ||
| 78 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.6 | NOK 121.4B | NOK 145.64 | 1.28% up | 5% up | ||
| 79 | Becton, DickinsonBDX · Health Care | 42.7 | NOK 572.2B | NOK 2,100.81 | 0.31% up | 43% up | ||
| 80 | Krystal BiotechKRYS · Health Care | 42.8 | NOK 90.9B | NOK 3,065.86 | 5.62% up | 46% up | ||
| 81 | GenmabGMAB · Health Care | 43.6 | NOK 305.6B | NOK 495.55 | 1.91% down | 70% up | ||
| 82 | Eli LillyLLY · Health Care | 44.9 | NOK 11.97T | NOK 13,443.63 | 2.32% down | 35% up | ||
| 83 | Royalty PharmaRPRX · Health Care | 44.9 | NOK 383.9B | NOK 667.64 | 0.01% down | 78% up | ||
| 84 | West Pharmaceutical ServicesWST · Health Care | 45.3 | NOK 273.6B | NOK 3,928.04 | 2.44% down | 61% up | ||
| 85 | IDEXX LaboratoriesIDXX · Health Care | 47.1 | NOK 535B | NOK 6,790.80 | 1.19% up | 1% down | ||
| 86 | BrightSpring Health ServicesBTSG · Health Care | 48.5 | NOK 132.2B | NOK 664.43 | 2.13% down | 116% up | ||
| 87 | AbbVieABBV · Health Care | 49.1 | NOK 4.92T | NOK 2,780.70 | 2.33% down | 26% up | ||
| 88 | Intuitive SurgicalISRG · Health Care | 50.9 | NOK 1.42T | NOK 4,092.64 | 2.23% down | 24% down | ||
| 89 | Corcept TherapeuticsCORT · Health Care | 51.0 | NOK 72.1B | NOK 659.08 | 3.25% down | 8% down | ||
| 90 | BeOne MedicinesONC · Health Care | 51.7 | NOK 448.2B | NOK 3,923.96 | 2.34% down | 17% up | ||
| 91 | HaemoneticsHAE · Health Care | 54.4 | NOK 54.4B | NOK 1,194.49 | 1.60% up | 61% up | ||
| 92 | Amneal PharmaceuticalsAMRX · Health Care | 54.7 | NOK 74.1B | NOK 212.73 | 3.60% up | 83% up | ||
| 93 | AlconALC · Health Care | 54.9 | NOK 351.5B | NOK 731.71 | 1.55% up | 2% down | ||
| 94 | IncyteINCY · Health Care | 60.1 | NOK 233.4B | NOK 1,145.30 | 1.08% down | 18% up | ||
| 95 | Edwards LifesciencesEW · Health Care | 61.2 | NOK 588.3B | NOK 1,023.09 | 0.19% down | 23% up | ||
| 96 | Bio-TechneTECH · Health Care | 66.7 | NOK 111.1B | NOK 707.30 | 0.17% up | 26% up | ||
| 97 | RevvityRVTY · Health Care | 67.7 | NOK 165.4B | NOK 1,481.98 | 3.14% up | 60% up | ||
| 98 | HeartflowHTFL · Health Care | 68.5 | NOK 39.2B | NOK 446.16 | 2.51% down | 73% up | ||
| 99 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 72.0 | NOK 72.6B | NOK 924.11 | 0.06% down | 126% up | ||
| 100 | Jazz PharmaceuticalsJAZZ · Health Care | 73.3 | NOK 154.6B | NOK 2,408.92 | 2.93% up | 37% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.7224 NOK). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies have the lowest P/E ratio?
Edgewise Therapeutics (4.9), Alnylam Pharmaceuticals (7.5) and Universal Health Services (7.8) have the lowest P/E ratio of the 115 health care companies ranked here as of 19 Nov 2026, 08:06 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of NOK 88.43T as of 19 Nov 2026, 08:06 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.